• Carrasco, J. M., B. Garcia, C. Andujr, F. Garrote, P. De Juana & T. Bermejo: Tendinitis associated with ciprofloxacin. Ann. Pharmacotherap. 1997, 31, 120.
  • Christ, W. & G. Esch: Adverse reactions to fluorochinolones in adults and children. Infect. Dis. Clin. Pract. 1994, 3, S168S176.
  • Hooper, D. C. & J. S. Wolfson: Adverse effects. In: Quinolone antimicrobial agents. Eds.: D. C.Hooper & J. S.Wolfson. American Society of Microbiology, New York, 1993, pp. 489512.
  • Kashida, Y. & M. Kato: Characterization of fluoroquinolone-induced Achilles tendon toxicity in rats: comparison of toxicities of 10 fluorochinolones and effects of anti-inflammatory compounds. Antimicrob. Agents Chemotherap. 1997a, 41, 23892393.
  • Kashida, Y. & M. Kato: Toxic effects of quinolone antibacterial agents on the musculoskeletal system in juvenile rats. Toxicol. Pathol. 1997b, 25, 635643.
  • Kato, M., S. Takada, Y. Kashida & M. Nomura: Histological examination on Achilles tendon lesions induced by quinolone antibacterial agents in juvenile rats. Toxicol. Pathol. 1995, 23, 385392.
  • NRC (National Research Council): Guide for the care and use of laboratory animals. National Research Council. National Academy, Washington, USA, 1996.
  • Oh, J. I., K. S. Paek, M. J. Ahn, M. Y. Kim, C. Y. Hong & I. C. Kim: In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone. Antimicrob. Agents Chemotherap. 1996, 40, 15641568.
  • Saravolatz, L. D. & J. Leggett: Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones. Clin. Infect. Dis. 2003, 37, 12101215.
  • Schaad, U. B.: Use of the quinolones in pediatrics. In: The quinolones, 3rd ed.. Ed.: V. T.Andriole. Academic Press, San Diego, 2000, pp. 455475.
  • Shakibaei, M., I. Baumann-Wilschke & R. Stahlmann: Quinolone-induced changes in Achilles tendons from rats persist for several months. J. Antimicrob. Chemotherap. 2001a, 47 (Suppl. S1), 49 (poster No. P130).
  • Shakibaei, M., P. Des Souza, D. Van Sickle & R. Stahlmann: Biochemical changes in Achilles tendon from juvenile dogs after treatment with ciprofloxacin or feeding a magnesium-deficient diet. Arch. Toxicol. 2001b, 75, 369374.
  • Shakibaei, M., K. Pfister, R. Schwabe, J. Vormann & R. Stahlmann: Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet. Antimicrob. Agents Chemotherap. 2000, 44, 261266.
  • Shakibaei, M. & R. Stahlmann: Ultrastructure of Achilles tendon from rats after treatment with fleroxacin. Arch. Toxicol. 2001, 75, 97102.
  • Simonin, M. A., P. Gegout-Pottie, A. Minn, P. Gillet, P. Netter & B. Terlain: Pefloxacin-induced Achilles tendon toxicity in rodents: biochemical changes in proteoglycan synthesis and oxidative damage to collagen. Antimicrob. Agents Chemotherap. 2000, 44, 867872.
  • Stahlmann, R.: Clinical toxicological aspects of fluoroquinolones. Toxicol. Letters 2002, 127, 269277.
  • Stahlmann, R. & H. Lode: Toxicity of quinolones. Drugs 1999, 58, 3742.
  • Stahlmann, R. & H. Lode: Fluoroquinolones in the elderly: safety considerations. Drugs Aging 2003, 20, 289302.
  • Takayama, S., M. Hirohashi, M. Kato & H. Shimada: Toxicity of quinolone antimicrobial agents. J. Toxicol. Environ. Health A 1995, 45, 145.